Financial statements Bioalco
Balance sheet of Bioalco
Company age:
Age:
4 y. 7 m. 14 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BIOALCO
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 831 738,00 | 1 017 236,56 | 881 459,83 |
| A. Fixed assets | 800 000,00 | 816 650,00 | 813 410,00 |
| B. Current assets | 31 738,00 | 200 586,56 | 68 049,83 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 831 738,00 | 1 017 236,56 | 881 459,83 |
| A. Equity | 805 000,00 | 830 004,82 | 760 518,87 |
| B. Liabilities and provisions for liabilities | 26 738,00 | 187 231,74 | 120 940,96 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 26 738,00 | 187 231,74 | 120 940,96 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.